Neoadjuvant pembrolizumab achieved a 71% pCR rate in desmoplastic melanoma, surpassing expectations for neoadjuvant anti–PD-1 treatment. The 3-year relapse-free survival rate was 74%, and the overall ...
A new comprehensive analysis has revealed that major depressive disorder alters both the physical architecture and the ...
HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
News Medical on MSN
Study uncovers genes and proteins likely to play a causal role in Type 2 diabetes
An international study co-led by researchers from the University of Massachusetts Amherst and Helmholtz Munich in Germany has ...
ScienceAlert on MSN
Boosting One Vitamin May Have a Surprising Effect on Your Poop Schedule
How often a person poops has a surprising link to one vitamin in particular. A genetic investigation on the rate at which ...
Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...
FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...
Low-level exposure to bisphenol A before birth can permanently alter metabolism, immunity, and disease risk in sex-specific ...
Euan Ashley's lab explores the intricate interactions of gene variants. Tiny "typos," or genetic mutations, can sneak into ...
Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...
Epigenomics is at the forefront of biomedical innovation, offering unprecedented insights into the mechanisms that regulate ...
Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results